Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors

BACKGROUND: Epidermal growth factor receptor (EGFR) signaling plays an important role in non-small cell lung cancer (NSCLC) and therapeutics targeted against EGFR have been effective in treating a subset of patients bearing somatic EFGR mutations. However, the cancer eventually progresses during tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Gargi, Lian, Xiaojun, Kron, Stephen J, Palecek, Sean P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364915/
https://www.ncbi.nlm.nih.gov/pubmed/22433462
http://dx.doi.org/10.1186/1471-2407-12-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364915/
https://www.ncbi.nlm.nih.gov/pubmed/22433462
http://dx.doi.org/10.1186/1471-2407-12-95

Ejemplares similares